TY - JOUR
T1 - Cryopreservation of adhered mammalian cells on a microfluidic device
T2 - Toward ready-to-use cell-based experimental platforms
AU - Kondo, Eitaro
AU - Wada, Ken Ichi
AU - Hosokawa, Kazuo
AU - Maeda, Mizuo
N1 - Publisher Copyright:
© 2015 Wiley Periodicals, Inc.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - In this paper, we describe cryopreservation of mammalian cells in the adhered state on a microfluidic device (microdevice) for the first time. HeLa, NIH3T3, MCF-7, and PC12 cells were cultured on a microdevice in which a commercial polystyrene dish surface was used as the cell adhesion surface. Without cell-detaching treatment, the microdevice was stored in a freezer at -80°C. After thawing, we observed a greater number of live cells on the microdevice than those on a control culture dish. Although the effectiveness of the microdevice varied depending on the cell type and surface coating, the trend was consistent. We confirmed that the phenotype of the PC12 cells to differentiate into neuron-like cells was kept after the on-chip cryopreservation, and that the results of cytotoxicity test of cisplatin against the HeLa cells were essentially unchanged by the on-chip cryopreservation. These findings will open up a new possibility of ready-to-use cell-based experimental platforms.
AB - In this paper, we describe cryopreservation of mammalian cells in the adhered state on a microfluidic device (microdevice) for the first time. HeLa, NIH3T3, MCF-7, and PC12 cells were cultured on a microdevice in which a commercial polystyrene dish surface was used as the cell adhesion surface. Without cell-detaching treatment, the microdevice was stored in a freezer at -80°C. After thawing, we observed a greater number of live cells on the microdevice than those on a control culture dish. Although the effectiveness of the microdevice varied depending on the cell type and surface coating, the trend was consistent. We confirmed that the phenotype of the PC12 cells to differentiate into neuron-like cells was kept after the on-chip cryopreservation, and that the results of cytotoxicity test of cisplatin against the HeLa cells were essentially unchanged by the on-chip cryopreservation. These findings will open up a new possibility of ready-to-use cell-based experimental platforms.
UR - http://www.scopus.com/inward/record.url?scp=84948089976&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84948089976&partnerID=8YFLogxK
U2 - 10.1002/bit.25704
DO - 10.1002/bit.25704
M3 - Article
C2 - 26174812
AN - SCOPUS:84948089976
SN - 0006-3592
VL - 113
SP - 237
EP - 240
JO - Biotechnology and Bioengineering
JF - Biotechnology and Bioengineering
IS - 1
ER -